Annette Vangsted

29PUBLICATIONS
145CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Medical infection agents (incl. prions)Urban informaticsEpigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (29)

|Oct 08, 2025
Circulating tumor cells predict myeloma outcomes in patients treated with daratumumab, bortezomib, lenalidomide, and dexamethasone.

Luca Bertamini, Cathelijne Fokkema, Paula Rodriguez-Otero

|Dec 05, 2024
Health-Related Quality of Life During Carfilzomib-Lenalidomide-Dexamethasone Consolidation: Findings From the Multiple Myeloma CONPET Study.

Tine Rosenberg, Sören Möller, Niels Abildgaard

|Aug 05, 2024
Deciphering the genetics and mechanisms of predisposition to multiple myeloma.

Molly Went, Laura Duran-Lozano, Gisli H Halldorsson

|Aug 11, 2023
Intensifying treatment in PET-positive multiple myeloma patients after upfront autologous stem cell transplantation.

Jakob Nordberg Nørgaard, Niels Abildgaard, Anna Lysén

|May 04, 2023
Management of patients with multiple myeloma and COVID-19 in the post pandemic era: a consensus paper from the European Myeloma Network (EMN).

Evangelos Terpos, Pellegrino Musto, Monika Engelhardt

|Nov 22, 2022
Geographical and ecological analyses of multiple myeloma in Denmark: Identification of potential hotspot areas and impact of urbanisation.

Lise Dueholm Bertelsen, Lars Børty Nielsen, Heidi Søgaard Christensen

Pageof 5

Frequent Collaborators

8 joint publications

Fredrik Schjesvold

6 joint publications

Emil Hermansen

5 joint publications

Agoston Gyula Szabo

4 joint publications

Federico Canzian